Oncodesign
Identification
Instrument name
ONCODESIGN
Symbol
ALONC
ISIN code
FR0011766229
Exchange / Market
Euronext Growth
Trading location
Paris
Products family
Stocks
ICB
Biotechnology
Activity description
Oncodesign est spécialisé dans la recherche et le développement de médicaments destinés au traitement du cancer. En outre, le groupe propose des prestations d’évaluation pharmacologique préclinique dans le domaine de l’oncologie.
Source: Cofisem
Website address
http://www.oncodesign.com
Operation
IPO date
Wed 02/04/2014
IPO type
Introduction par offre au public
IPO price
7,34 EUR
IPO type
Initial Public offering
Catégorie
IPO
Price range
EUR 6.42 - EUR 7.34
Capital raised
12,8
Company profile
ONCODESIGN specializes in preclinical pharmacological evaluation services of new cancer therapies on behalf of the pharmaceutical and biotechnological companies. The group also provides research and development of drugs and biomarkers primarily for the treatment of cancer. The group's activity is organized around 3 business units:
- Service: discovery, identification and selection of new therapeutic targets in oncology;
- Biotech: development of a portfolio of therapeutic and diagnostic projects alone or through partnerships;
- Artificial Intelligence: development of a platform for selecting new therapeutic targets in oncology.
Source:
Cofisem
-
Last Update:
13 Dec 2022
Key Executives
| Chief Executive Officer | Fabrice Viviani | ||||
| Source: Cofisem - Last Update: 14 Nov 2022 | |||||
Key figures
| Millenium | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|
| Net sales | 31.310 | 25.507 | 26.911 | 20.087 | 14.305 |
| Consumed purchases | 2.395 | 8.886 | |||
| Personnal costs | 17.916 | 17.491 | 18.056 | 15.987 | 12.869 |
| Operating profit | -898 | 1.473 | 668 | -3.814 | -4.361 |
| Income tax | -45 | -376 | -256 | 1 | 256 |
| Net income | -288 | 2.103 | 1.625 | -3.150 | -5.001 |
| Net consolidated income (Group share) | -288 | 2.103 | 1.625 | -3.150 | -5.001 |
| Fiscal year end | 12,21 | 12,20 | 12,19 | 12,18 | 12,17 |
| Length of fiscal year (month) | 12 | 12 | 12 | 12 | 12 |
| Currency & Unit | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands |
| Account Standards | |||||
| Source: Cofisem - Last Update: 13 Dec 2022 | |||||